Metformin treatment enhances insulin-stimulated glucose transport in skeletal muscle of Sprague-Dawley rats

Citation
Se. Borst et al., Metformin treatment enhances insulin-stimulated glucose transport in skeletal muscle of Sprague-Dawley rats, LIFE SCI, 67(2), 2000, pp. 165-174
Citations number
25
Categorie Soggetti
Biochemistry & Biophysics
Journal title
LIFE SCIENCES
ISSN journal
00243205 → ACNP
Volume
67
Issue
2
Year of publication
2000
Pages
165 - 174
Database
ISI
SICI code
0024-3205(20000602)67:2<165:MTEIGT>2.0.ZU;2-B
Abstract
Although the glucose-lowering properties of metformin are well-established, its effects on glucose metabolism in skeletal muscle have not been clearly defined. We tested the effects of metformin in young adult male Sprague-Da wley rats, which have a documented reduced response to insulin in skeletal muscle. Rats were treated with metformin for 20 days (320 mg/kg/day) in the drinking water. During this period, metformin completely prevented the inc rease in food intake and decreased adiposity by 30%. Metformin also reduced insulin secretion by 37% following an intra-peritoneal injection of glucos e. Finally, metformin enhanced transport of [H-3]-2-deoxyglucose in isolate d strips of soleus muscle. Metformin substantially increased insulin-stimul ated transport, while having no effect on basal transport. In control rats, a maximal concentration of insulin stimulated transport 77% above basal. I n metformin-treated rats, insulin stimulated transport 206% above basal. We conclude that in the Sprague-Dawley rat model, metformin causes a signific ant increase in insulin-responsiveness. (C) 2000 Elsevier Science Inc. All rights reserved.